Menu
Log in



2022 STOCKHOLM MEETING AGENDA

Please note - All meetings on Days 1 and 2 will take place at the BioClinicum Research Center at the Karolinska University Hospital Solna.  All meetings on Days 3 and 4 will take place at the Grand Hotel

Day 1 - Saturday, September 17, 2022
1000 - 1600     Executive Board Meeting*
1230 - 1330     Lunch (Board)
1600 - 1630     Coffee Break (Board + Steering Committee members)
1630 - 1800     LCH Steering Committee Meeting*
1630 - 1800     Rare Histiocytic Disorders Steering Committee Meeting*

Day 2 - Sunday, September 18, 2022
0800 - 1700     Meeting Registration and Check-In
0830 - 0930     LCH-IV Study Management Group*
0830 - 0930 LCH in Adults Sub Committee Meeting*
0830 - 1000     HLH Education Session - Rebecca Marsh, Despina Moshous and Kim Nichols
0930 - 1000     Coffee Break
1000 - 1230     LCH Disease Discussion Session
1030 - 1200 HLH in Adults Working Group Meeting*
1115 - 1215 Rare Histiocytoses Education Session - Eli Diamond and Jean-Francois Emile
1230 - 1330     Lunch 
1230 - 1330 Young Investigators/New Members Lunch w/ Executive Board
1330 - 1500     Rare Histiocytic Disorders Discussion Session
1330-1335 Introduction - Eli Diamond
                                 1335-1345 International Rare Histiocytic Disorders Registry - Oussama Abla
1345-1355 
Malignant Histiocytosis Classification - Jennifer Picarsic 
                        1355-1410 Mutational Landscape of Rare Histiocytic Disorders - Benjamin Durham
                        1410-1425 National Cancer Center Network Guidelines for Histiocytic Neoplasms - Paul Hendrie
                        1425-1440 2021-2022 Rosai-Dorfman Disease updates - Julien Haroche                     
1440-1450 2021-2022 Community Perspective on Rare Histiocytic Disorders - Deanna Fournier 

                        1450-1500 Additional questions and discussion - Eli Diamond

1345 - 1515     LCH Education Session - Matthew Collin and Caroline Hutter 
1500 - 1530    Coffee Break
1530 - 1800     HLH Disease and MAS Discussion Session
1530 - 1535 - Introduction – Kim Nichols, Rebecca Marsh
1535 - 1615 - Working group updates - Karin Beutel, Jan Inge Henter, Kai Lehmberg, Adi Zoref Lorenz
1615 - 1655 - Clinical Trial updates - Claudia Bracaglia, Melissa Hines, Despina Moshous, Rebecca Marsh
1655 - 1700 - Update on NIH consensus statement – Rebecca Marsh
1700 - 1730 - New/ongoing initiatives in HLH - Michael Jordan, Claudia Bracaglia, Despina
1730 - 1755 - CAR T-cells and HLH - Nirali Shah
1755 - 1800 - Closing - Kim Nichols, Rebecca Marsh

1930 - 2130     Welcome Reception at Stockholm City Hall
Note: Doors open at 1900 and attendees MUST arrive between 1900-1930 or access will not be granted
(Pre-registered only)+

Day 3 - Monday, September 19, 2022
0800 - 1700     Meeting Registration and Check-In
0800 - 0845     Education Committee Meeting*
                        Scientific Committee Meeting*

0845 - 0900     Opening Ceremonies: Histiocyte Society President and Local Organizer
0900 - 0930     Scientific Session 1, Part 1: Oral Presentations
0930 - 0950     Coffee Break
0930 - 1200     Poster Presentation Set-Up
0950 - 1000  Break (while seated)
1000 - 1005 Her Majesty Queen Silvia enters

1005 - 1125 Special Scientific Session with Her Majesty Queen Silvia: Progress and Challenges in Histiocytic Disorders
Progress and Challenges in Hemophagocytic Lymphohistiocytosis - Jan-Inge Henter
Progress and Challenges in Langerhans Cell Histiocytosis - Carl Allen
Special Guest Speaker: Immune System Regulation and Dysregulation in COVID-19 - Petter Brodin
1130 - 1200 Her Majesty Queen Silvia meets patients and parents
1130 - 1200 Scientific Session 1, Part 2: Oral Presentations
1200 - 1300 Lunch
1200 - 1300 Family Group Representative Luncheon/Meeting - Part 1
1200 - 1300 Meet the Expert - HLH - Kai Lehmberg
1300 - 1500 HLH Symposium: Expanding/Refining Our Understanding of Harmful Immune Activation
Hyperferritinemic Sepsis and Multiple Organ Dysfunction Syndrome - Joe Carcillo
Hyperinflammation, Cytokine Release Syndrome, and HLH with CAR-T cell therapy - David Teachey
The outcome of macrophage activation syndrome is determined by the interplay between mode of cell death, HMGB1, and acetylcholine - Ulf Andersson

1500 - 1530  Coffee Break
1500 - 1530  Judging of Posters 1-5 for Arceci Prize
1530 - 1700 Scientific Session II: Presidential Symposium
1700 - 1830 Poster Presentation Session
1900 - ? Optional Excursions
Choice 1: ABBA Museum and Dinner+
Choice 2: Dinner Cruise+

Day 4 - Tuesday, September 20, 2022
0800 - 1300     Meeting Registration and Check-In
0830 - 0930     Clinical Studies and Registries Update
0930 - 1000     Speaker: Jon Pritchard Lecture on the Nikolas Symposium - Astrid van Halteren
1000 - 1030     Coffee Break
1000 - 1030 Judging of Posters 6-10 for Arceci Prize
1030 - 1230     LCH Symposium: New Horizons for LCH
                        Early Inhibitor Therapy for LCH - Ashish Kumar
Long Term Inhibitor Therapy for LCH - Jean Donadieu
MEK inhibitors in pediatric oncology and rare diseaases: Current roles and future possibilities  - Brigitte Widemann

1230 - 1330     Lunch
1230 - 1330     Meet the Expert - LCH - Milen Minkov
                        Meet the Expert - Rare Histiocytoses - Julien Haroche
1230 - 1330 Family Group Representative Luncheon/Meeting - Part 2

1330 - 1500     Scientific Session III: Oral Presentations
1500 - 1510     Presentation of Late Breaking Abstracts
1510 - 1540  Coffee Break
1545 - 1645     General Assembly Business Meeting*
1645 - 1715     Executive Board Meeting*
                        Education Committee Meeting
*
                        Scientific Committee Meeting*
1900 - 0100     Histiocyte Society Annual Banquet
                        Closing Ceremonies: Awarding of Scientific Prizes


* Indicates closed session
+ Indicates advance registration required


About the Society

The Histiocyte Society is a nonprofit organization of more than 200 physicians and scientists from around the world committed to improving the lives of patients with histiocytic disorders by conducting clinical and laboratory research into the causes and treatment of this disease.

Copyright © 2020 Histiocyte Society

Contact

secretariat@histiocytesociety.org
Phone: +1 856 589 6606 
Fax: +1 856 589 6614
332 N Broadway
Pitman, NJ 08071 USA

Powered by Wild Apricot Membership Software